Support for Overall Recovery: For individuals undergoing treatment for arthritis, BPC 157 may support overall recovery by enhancing the bodys natural healing processes
Composition GHK-Cu: 50 mg BPC-157: 10 mg TB-500 (Thymosin Beta 4): 10 mg Appearance: lyophilized powder in a sealed research vial Research Focus (non-clinical) Combined evaluation of copper peptide, BPC-157, and TB-500 in in-vitro or ex-vivo assay systems Assay development, including chromatographic separation of three co-formulated peptides Stability characterization of a three-analyte lyophilized blend under laboratory storage conditions Method documentation for HPLC/LC-MS identity and purity assessments Documentation Analysis Report Important Notice For research use only Not for human consumption Not intended to diagnose, treat, cure, or prevent any disease Quality & Manufacturing Lot-specific COA Lyophilized for transit stability

Key Features Research Use Only (RUO) compound 5 mg per bottle Spray format for convenient handling in laboratory settings Manufactured and packaged for research applications Product Specifications Compound Name: BPC-157 Form: Spray Total Quantity: 5 mg per bottle Grade: Research Use Only (RUO) Intended Use This product is intended solely for laboratory research and investigational purposes
The activation of ALT can lead to suppression of telomerase activity (OSullivan et al 2014) hence, we observed no increase in telomerase enzyme activity in the cancer cells after treatment with epitalon
The system creates barriers that are structural rather than scientific
Chemical & Handling Information Type: Synthetic FOXO4-interacting peptide analog Peptide length: Short peptide (exact sequence per specification/lot) Appearance: White to off-white lyophilized powder Specifications Peptide: FOXO4-DRI Amount: 5 mg per vial Form: Lyophilized powder Purity: 99% (HPLC)